Summary
Updated Aug 30, 2026
Francis Duhay is Director of enVVeno Medical Corp (NVNO). 5 SEC Form 4 filings on record going back to 2024, most recently on 12 June 2026. Most recent open-market trade: sold $1K of NVNO on 12 June 2026. Lifetime open-market sales: $9K.
Recent Transactions
4Every recent SEC Form 4 transaction Francis Duhay has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Francis Duhay. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert Andrew Berman - $31K of NVNO open-market activity on record
- Matthew Jenusaitis - $24K of NVNO open-market activity on record
- Sanjay Shrivastava - $16K of NVNO open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Francis Duhay?
Francis Duhay is a corporate insider, tracked as Director of enVVeno Medical Corp (NVNO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Francis Duhay submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Francis Duhay been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($9K) across all tracked filings.
Where can I see all of Francis Duhay's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Francis Duhay and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
